Published in Rev Esp Cardiol on December 01, 2002
Divergent mitochondrial biogenesis responses in human cardiomyopathy. Circulation (2013) 1.69
Protein kinase Cepsilon interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning. Biochem J (2006) 1.23
Mitochondrial 8-oxoguanine glycosylase decreases mitochondrial fragmentation and improves mitochondrial function in H9C2 cells under oxidative stress conditions. Am J Physiol Cell Physiol (2013) 0.84
A delta-sarcoglycan gene polymorphism as a risk factor for hypertrophic cardiomyopathy. Genet Test Mol Biomarkers (2012) 0.80
Quercetin Affects Erythropoiesis and Heart Mitochondrial Function in Mice. Oxid Med Cell Longev (2015) 0.75
Cardiovascular Disease, Mitochondria, and Traditional Chinese Medicine. Evid Based Complement Alternat Med (2015) 0.75
Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol (2002) 1.39
Mitochondrial centrality in heart failure. Heart Fail Rev (2008) 1.28
Heart mitochondria signaling pathways: appraisal of an emerging field. J Mol Med (Berl) (2004) 0.94
Akt signaling pathway in pacing-induced heart failure. Mol Cell Biochem (2005) 0.92
Mitochondria play a critical role in cardioprotection. J Card Fail (2004) 0.89
Mitochondrial involvement in IGF-1 induced protection of cardiomyocytes against hypoxia/reoxygenation injury. Mol Cell Biochem (2007) 0.88
Regional distribution of mitochondrial dysfunction and apoptotic remodeling in pacing-induced heart failure. J Card Fail (2009) 0.88
Mitochondrial Ca2+ flux and respiratory enzyme activity decline are early events in cardiomyocyte response to H2O2. J Mol Cell Cardiol (2004) 0.87
Oxidative stress enhances phosphorylation of p53 in neonatal rat cardiomyocytes. Mol Cell Biochem (2007) 0.87
Understanding the impact of mitochondrial defects in cardiovascular disease: a review. J Card Fail (2002) 0.86
Mitochondrial-nuclear cross-talk in the aging and failing heart. Cardiovasc Drugs Ther (2006) 0.86
Fatty acid metabolism in cardiac failure: biochemical, genetic and cellular analysis. Cardiovasc Res (2002) 0.82
Severe mitochondrial cytopathy with complete A-V block, PEO, and mtDNA deletions. Pediatr Neurol (2002) 0.81
Mitochondrial channelopathies in aging. J Mol Med (Berl) (2007) 0.81
Application of stem cells in cardiology: where we are and where we are going. Curr Stem Cell Res Ther (2006) 0.81
Mutations in the cardiac mitochondrial DNA control region associated with cardiomyopathy and aging. J Card Fail (2002) 0.80
Buccal swab analysis of mitochondrial enzyme deficiency and DNA defects in a child with suspected myoclonic epilepsy and ragged red fibers (MERRF). J Child Neurol (2011) 0.79
Cardiomyopathy associated with neurologic disorders and mitochondrial phenotype. J Child Neurol (2002) 0.77
Selective endothelin receptor blockade reverses mitochondrial dysfunction in canine heart failure. J Card Fail (2002) 0.76
Probing striated muscle mitochondrial phenotype in neuromuscular disorders. Pediatr Neurol (2003) 0.75
Mitochondrial DNA depletion in Leigh syndrome. Pediatr Neurol (2002) 0.75